Overview

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Status:
Completed
Trial end date:
2019-06-26
Target enrollment:
Participant gender:
Summary
A phase 3 trial comparing the efficacy and safety of LEO 90100 aerosol foam with the aerosol foam vehicle used twice weekly as long-term maintenance therapy in subjects with psoriasis vulgaris. A 12-month, international, multi-centre, randomised, vehicle controlled, double-blind, 2-arm, parallel group trial.
Phase:
Phase 3
Details
Lead Sponsor:
LEO Pharma